Skip to content

Neural Correlates of Repeated tDCS

Investigating the Neural Correlates of Repeated tDCS in MCI and Healthy Ageing With fMRI

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02997007
Enrollment
80
Registered
2016-12-19
Start date
2017-05-02
Completion date
2018-12-31
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

tDCS, Mild Cognitive Impairment, fMRI, Healthy ageing

Brief summary

Healthy ageing and pathological ageing in the context of a neurodegenerative disease are both associated with changes in brain network integrity. Episodic memory is especially affected in Alzheimer's disease, but is also decreased in healthy ageing. Consequently, the memory-relevant brain networks are especially altered. Transcranial direct current stimulation (tDCS) has previously been implemented in different clinical- and non-clinical settings and has shown to beneficially influence network connectivity. The neural correlates of single-session tDCS have been investigated, however, the neural effects of repeated tDCS remain unknown. Furthermore, knowledge about the (long-term) neural mechanisms of repeated tDCS can give valuable insights and possibly pave the ground for exploring tDCS as a treatment option in future studies.

Interventions

DEVICEactive tDCS

Participants will receive active tDCS over the angular gyrus on five consecutive days

DEVICEsham tDCS

Participants will receive sham tDCS over the angular gyrus on five consecutive days

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Patients * Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic (prof. Frans RJ Verhey): presence of at least a memory impairment, memory complaints expressed by the patient or informant, no problems in daily life functioning, no dementia and presence of biomarkers (Albert et al., 2011) * Clinical Dementia Rating score of 0.5 (CDR distinguishes a stage of questionable dementia (CDR 0.5) from people termed healthy (CDR 0) and those with mild dementia (CDR 1) * Mini-Mental State Examination (MMSE) 23 and being mentally competent (in general, individuals with a MMSE 18 are considered mentally competent) * Age: between 60 and 85 years old * 50% female * Right-handedness * Average level of education (CBS level 3-4-5-6) Healthy controls * Average neuropsychological test results, in accordance with normative data, corrected for age, education and gender * No substantial memory complaints (according to the participant) * Age: between 60 and 85 years old * 50% female * Right-handedness * Average level of education (CBS level 3-4-5-6) * Normal or corrected to normal vision

Exclusion criteria

* Psychoactive medication use * Abuse of alcohol and drugs * Cognitive impairment due to alcohol/drug abuse or abuse of other substances * Past or present psychiatric or neurological disorders (major depression, schizophrenia, bipolar disorder, psychotic disorder (or treatment for it), epilepsy, stroke, Parkinson's disease, multiple sclerosis, brain surgery, brain trauma, electroshock therapy, kidney dialysis, Menière's disease, brain infections) * Major vascular disorders (e.g. stroke) * Heart diseases or pacemakers * Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, body tattoos) * Large scars or fresh wounds on the scalp

Design outcomes

Primary

MeasureTime frameDescription
neural changes after multi-session tDCS5-12 daysfMRI-BOLD response
network changes after multi-session tDCS5-12 daysfunctional connectivity between network hubs

Secondary

MeasureTime frameDescription
Task performance changes after multi-session tDCS5-12 daysBPS-score

Countries

Netherlands

Contacts

Primary ContactLisa Müller-Ehrenberg, MSc
l.muller-ehrenberg@maastrichtuniversity.nl0031433881025
Backup ContactHeidi IL Jacobs, PhD
h.jacobs@maastrichtuniversity.nl0031433884090

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026